Dissemination and analysis of the quality assurance (QA) and quality control (QC) practices of LC–MS based untargeted metabolomics practitioners
暂无分享,去创建一个
Thomas Hartung | Richard D Beger | John A. Bowden | Maureen Kachman | Tao Huan | John A Bowden | Federico Torta | Julian L Griffin | Andre Kleensang | María Eugenia Monge | Surendra Dasari | David Broadhurst | Claire O'Donovan | Matthew R Lewis | Chris Beecher | Christina M Jones | Georgios Theodoridis | Christina M. Jones | Anne M Evans | Mary Playdon | Clary B Clish | Warwick B Dunn | Ping- Ching Hsu | Judith Jans | Jonathan D Mosley | Eric Taylor | Fariba Tayyari | Baljit K Ubhi | Dajana Vuckovic | C. O’Donovan | W. Dunn | T. Hartung | D. Broadhurst | C. Clish | J. Griffin | F. Torta | R. Beger | G. Theodoridis | Fariba Tayyari | B. Ubhi | T. Huan | S. Dasari | J. Jans | D. Vuckovic | C. Beecher | M. Monge | A. Kleensang | M. Playdon | M. Kachman | P. Hsu | M. Lewis | Anne M Evans | Eric Taylor | Jonathan D. Mosley | W. Dunn | Anne M. Evans | Eric B Taylor
[1] Richard Nicholas,et al. Breaking the cycle , 2019, Neurology: Neuroimmunology & Neuroinflammation.
[2] I. Wilson,et al. Evaluation of the repeatability of ultra-performance liquid chromatography-TOF-MS for global metabolic profiling of human urine samples. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[3] Richard D. Beger,et al. Towards quality assurance and quality control in untargeted metabolomics studies , 2019, Metabolomics.
[4] Tariq Shafi,et al. Serum Metabolites and Cardiac Death in Patients on Hemodialysis. , 2019, Clinical journal of the American Society of Nephrology : CJASN.
[5] Jiang He,et al. Novel serum metabolites associate with cognition phenotypes among Bogalusa Heart Study participants , 2019, Aging.
[6] Thomas Hartung,et al. Review: Toxicometabolomics , 2013, Journal of applied toxicology : JAT.
[7] Stephen Burgess,et al. Assessing the causal association of glycine with risk of cardio-metabolic diseases , 2019, Nature Communications.
[8] Douglas B. Kell,et al. Molecular phenotyping of a UK population: defining the human serum metabolome , 2014, Metabolomics.
[9] David A Fields,et al. Maternal obesity and the human milk metabolome: associations with infant body composition and postnatal weight gain. , 2019, The American journal of clinical nutrition.
[10] L. Smirnova,et al. Metabolomics in toxicology and preclinical research. , 2013, ALTEX.
[11] Natalia Chueca,et al. Association of breast and gut microbiota dysbiosis and the risk of breast cancer: a case-control clinical study , 2019, BMC Cancer.
[12] Matej Oresic,et al. Metabolomics Analytics Workflow for Epidemiological Research: Perspectives from the Consortium of Metabolomics Studies (COMETS) , 2019, Metabolites.
[13] Denise J. Roe,et al. Deciphering the complex interplay between microbiota, HPV, inflammation and cancer through cervicovaginal metabolic profiling , 2019, EBioMedicine.
[14] Kishu Manghani,et al. Quality assurance: Importance of systems and standard operating procedures , 2011, Perspectives in clinical research.
[15] I. Wilson,et al. Within-day reproducibility of an HPLC-MS-based method for metabonomic analysis: application to human urine. , 2007, Journal of proteome research.
[16] Alexandra Maertens,et al. t4 Workshop Report , 2017, ALTEX.
[17] Melanie Waldenberger,et al. Exposure to disinfection byproducts and risk of type 2 diabetes: a nested case–control study in the HUNT and Lifelines cohorts , 2019, Metabolomics.
[18] Richard D Beger,et al. Pharmacometabolomic Pathway Response of Effective Anticancer Agents on Different Diets in Rats with Induced Mammary Tumors , 2019, Metabolites.
[19] A. Smilde,et al. Fusion of mass spectrometry-based metabolomics data. , 2005, Analytical chemistry.
[20] Pierre Baldi,et al. Time of Exercise Specifies the Impact on Muscle Metabolic Pathways and Systemic Energy Homeostasis. , 2019, Cell metabolism.
[21] E. Hsiao,et al. The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet , 2018, Cell.
[22] John P. Overington,et al. An atlas of genetic influences on human blood metabolites , 2014, Nature Genetics.
[23] John C. Earls,et al. Blood metabolome predicts gut microbiome α-diversity in humans , 2019, Nature Biotechnology.
[24] Elizabeth T. Cirulli,et al. Profound Perturbation of the Metabolome in Obesity Is Associated with Health Risk , 2019, Cell metabolism.
[25] I. Wilson,et al. A pragmatic and readily implemented quality control strategy for HPLC-MS and GC-MS-based metabonomic analysis. , 2006, The Analyst.
[26] A. Smilde,et al. Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation. , 2006, Analytical chemistry.
[27] Li Chen,et al. Sodium Reduction, Metabolomic Profiling, and Cardiovascular Disease Risk in Untreated Black Hypertensives. , 2019, Hypertension.
[28] Oliver Fiehn,et al. Preanalytical Processing and Biobanking Procedures of Biological Samples for Metabolomics Research: A White Paper, Community Perspective (for "Precision Medicine and Pharmacometabolomics Task Group"-The Metabolomics Society Initiative). , 2018, Clinical chemistry.
[29] Joshua D. Knowles,et al. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry , 2011, Nature Protocols.
[30] Inês Laíns,et al. Human Plasma Metabolomics in Age-Related Macular Degeneration: Meta-Analysis of Two Cohorts , 2019, Metabolites.
[31] Aleksandar Milosavljevic,et al. Untargeted Metabolomic Profiling Reveals Multiple Pathway Perturbations and New Clinical Biomarkers in Urea Cycle Disorders , 2019, Genetics in Medicine.
[32] Erik Schultes,et al. The FAIR Guiding Principles for scientific data management and stewardship , 2016, Scientific Data.
[33] Christian Gieger,et al. Metabolomics Identifies Novel Blood Biomarkers of Pulmonary Function and COPD in the General Population , 2019, Metabolites.
[34] Nigel W. Hardy,et al. Proposed minimum reporting standards for chemical analysis , 2007, Metabolomics.
[35] Pim E G Leonards,et al. Use cases, best practice and reporting standards for metabolomics in regulatory toxicology , 2019, Nature Communications.
[36] Nagireddy Putluri,et al. Liver- and Microbiome-derived Bile Acids Accumulate in Human Breast Tumors and Inhibit Growth and Improve Patient Survival , 2019, Clinical Cancer Research.
[37] Richard D. Beger,et al. Quality assurance and quality control processes: summary of a metabolomics community questionnaire , 2017, Metabolomics.
[38] Zaid Abdo,et al. Rice bran supplementation modulates growth, microbiota and metabolome in weaning infants: a clinical trial in Nicaragua and Mali , 2019, Scientific Reports.
[39] Evgeni Levin,et al. Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time , 2019, Gut.
[40] Chrysanthi Ainali,et al. Genome-wide association study in frontal fibrosing alopecia identifies four susceptibility loci including HLA-B*07:02 , 2019, Nature Communications.
[41] Lawrence J Appel,et al. The Serum Metabolome Identifies Biomarkers of Dietary Acid Load in 2 Studies of Adults with Chronic Kidney Disease. , 2019, The Journal of nutrition.
[42] E. Segal,et al. Potential roles of gut microbiome and metabolites in modulating ALS in mice , 2019, Nature.
[43] Ying Wang,et al. Metabolomic markers of healthy dietary patterns in US postmenopausal women. , 2019, The American journal of clinical nutrition.
[44] David Broadhurst,et al. The importance of experimental design and QC samples in large-scale and MS-driven untargeted metabolomic studies of humans. , 2012, Bioanalysis.
[45] Ian D. Wilson,et al. Guidelines and considerations for the use of system suitability and quality control samples in mass spectrometry assays applied in untargeted clinical metabolomic studies , 2018, Metabolomics : Official journal of the Metabolomic Society.
[46] Coral Barbas,et al. Quality assurance procedures for mass spectrometry untargeted metabolomics. a review , 2018, Journal of pharmaceutical and biomedical analysis.
[47] Stephen E. Stein,et al. Metabolite profiling of a NIST Standard Reference Material for human plasma (SRM 1950): GC-MS, LC-MS, NMR, and clinical laboratory analyses, libraries, and web-based resources. , 2013, Analytical chemistry.
[48] O. D. Rangel-Huerta,et al. Metabolic profiling in children with autism spectrum disorder with and without mental regression: preliminary results from a cross-sectional case–control study , 2019, Metabolomics.
[49] Donna M. Muzny,et al. Leveraging Human Microbiome Features to Diagnose and Stratify Children with Irritable Bowel Syndrome , 2019, The Journal of molecular diagnostics : JMD.
[50] Jörg Hackermüller,et al. Framework for the quality assurance of ’omics technologies considering GLP requirements , 2017, Regulatory toxicology and pharmacology : RTP.
[51] Rima Kaddurah-Daouk,et al. Untargeted Metabolomic Profiling Identifies Disease-specific Signatures in Food Allergy and Asthma. , 2019, The Journal of allergy and clinical immunology.
[52] Joshua D. Knowles,et al. Development of a robust and repeatable UPLC-MS method for the long-term metabolomic study of human serum. , 2009, Analytical chemistry.